Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume $1.56 +0.03 (+1.90%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Evaxion Biotech A/S Short Interest DataEvaxion Biotech A/S (EVAX) has a short interest of 23,300 shares, representing 1.83% of the float (the number of shares available for trading by the public). This marks a -44.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 599,059 shares to cover all short positions.Current Short Interest23,300 sharesPrevious Short Interest41,800 sharesChange Vs. Previous Month-44.26%Dollar Volume Sold Short$31,455.00Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares1,403,000 sharesFloat Size1,270,000 sharesShort Percent of Float1.83%Today's Trading Volume1,466 sharesAverage Trading Volume599,059 sharesToday's Volume Vs. Average0% Short Selling Evaxion Biotech A/S? Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVAX Short Interest Over TimeEVAX Days to Cover Over TimeEVAX Percentage of Float Shorted Over Time Evaxion Biotech A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202523,300 shares $31,455.00 -44.3%1.8%0 $1.35 3/31/202541,800 shares $77,330.00 +86.6%3.3%0 $1.85 3/15/202522,400 shares $39,872.00 -74.2%2.1%0 $1.78 2/28/202586,700 shares $168,198.00 +48.0%8.2%0 $1.94 2/15/202558,600 shares $145,914.00 -52.9%5.5%0 $2.49 1/31/2025124,500 shares $305,025.00 +21.7%N/A0.1 $2.45 1/15/2025102,300 shares $336,567.00 -89.6%N/A0.1 $3.29 12/31/2024980,100 shares $4.14 million +709.3%N/A2.9 $4.23 12/15/2024121,100 shares $138,054.00 +285.7%N/A2 $1.14 11/30/202431,400 shares $52,124.00 -12.8%N/A0.6 $1.66 Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 11/15/202436,000 shares $53,280.00 -31.6%N/A0.7 $1.48 10/31/202452,600 shares $137,812.00 -22.0%N/A1.1 $2.62 10/15/202467,400 shares $181,306.00 -21.1%N/A1.4 $2.69 9/30/202485,400 shares $265,594.00 +286.4%N/A1.7 $3.11 9/15/202422,100 shares $66,300.00 -35.2%N/A0.6 $3.00 8/31/202434,100 shares $104,005.00 -24.9%N/A0.8 $3.05 8/15/202445,400 shares $135,746.00 +9.4%N/A1.1 $2.99 7/31/202441,500 shares $118,690.00 -20.4%N/A1.1 $2.86 7/15/202452,100 shares $164,115.00 -40.8%N/A1.4 $3.15 6/30/202488,000 shares $255,200.00 +93.8%N/A2.3 $2.90 6/15/202445,400 shares $140,740.00 +6.3%N/A1 $3.10 5/31/202442,700 shares $156,709.00 -10.9%N/A1.5 $3.67 5/15/202447,900 shares $180,104.00 -10.0%N/A1.4 $3.76 4/30/202453,200 shares $222,908.00 +11.3%N/A1 $4.19 4/15/202447,800 shares $195,980.00 +12.2%N/A0.1 $4.10 3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20 3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99 2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60 2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15 1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93 1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99 12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69 12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66 11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80 11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75 10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12 10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85 9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83 9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75 8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01 7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24 7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26 6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30 6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30 5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52 5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57 4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26 4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.56 3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13 3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08 2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54 2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57 1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61 1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55 12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78 12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00 11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18 11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36 10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60 10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92 9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63 9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06 8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35 8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93 7/31/2022194,600 shares $595,476.00 +6.5%N/A0.5 $3.06 7/15/2022182,700 shares $442,134.00 -9.8%N/A0.5 $2.42 6/30/2022202,600 shares $388,992.00 +13.1%N/A0.5 $1.92 6/15/2022179,100 shares $300,888.00 +3.0%N/A0.5 $1.68 5/31/2022173,900 shares $340,844.00 -35.6%N/A0.5 $1.96 5/15/2022270,100 shares $469,974.00 +4,810.9%N/A0.7 $1.74 4/30/20225,500 shares $15,400.00 -41.5%N/A0.2 $2.80 4/15/20229,400 shares $27,072.00 -34.7%N/A0.2 $2.88 3/31/202214,400 shares $43,632.00 +84.6%N/A0.2 $3.03 3/15/20227,800 shares $20,826.00 +116.7%N/A0.1 $2.67 2/28/20223,600 shares $10,944.00 -82.0%N/A0 $3.04 2/15/202220,000 shares $63,800.00 -58.6%N/A0.1 $3.19 1/31/202248,300 shares $151,662.00 -3.0%N/A0.2 $3.14 1/15/202249,800 shares $203,682.00 +28.7%N/A0 $4.09 12/31/202138,700 shares $171,054.00 +25.7%N/A0 $4.42 12/15/202130,800 shares $126,588.00 +37.5%N/A0 $4.11 11/30/202122,400 shares $104,384.00 -57.1%N/A0 $4.66 11/15/202152,200 shares $324,162.00 +78.2%N/A0.1 $6.21 10/29/202129,300 shares $222,973.00 +229.2%N/A0 $7.61 10/15/20218,900 shares $70,488.00 -77.2%N/A0.1 $7.92 9/30/202139,000 shares $375,960.00 -27.9%N/A0.4 $9.64 9/15/202154,100 shares $444,161.00 +57.7%N/A0.6 $8.21 8/31/202134,300 shares $223,979.00 -2.8%N/A0.3 $6.53 8/13/202135,300 shares $205,093.00 No ChangeN/A0.5 $5.81 EVAX Short Interest - Frequently Asked Questions What is Evaxion Biotech A/S's current short interest? Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 23,300 shares of EVAX short. 1.83% of Evaxion Biotech A/S's shares are currently sold short. Learn More on Evaxion Biotech A/S's current short interest. Which institutional investors are shorting Evaxion Biotech A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evaxion Biotech A/S: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Evaxion Biotech A/S? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.83% of Evaxion Biotech A/S's floating shares are currently sold short. Is Evaxion Biotech A/S's short interest increasing or decreasing? Evaxion Biotech A/S saw a drop in short interest in April. As of April 15th, there was short interest totaling 23,300 shares, a drop of 44.3% from the previous total of 41,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evaxion Biotech A/S's float size? Evaxion Biotech A/S currently has issued a total of 1,403,000 shares. Some of Evaxion Biotech A/S's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evaxion Biotech A/S currently has a public float of 1,270,000 shares. How does Evaxion Biotech A/S's short interest compare to its competitors? 1.83% of Evaxion Biotech A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evaxion Biotech A/S: PharmaCyte Biotech, Inc. (0.35%), Mainz Biomed (2.40%), Creative Medical Technology Holdings, Inc. (2.57%), Carisma Therapeutics, Inc. (1.60%), HCW Biologics Inc. (1.33%), Talphera, Inc. (1.13%), Ainos, Inc. (86.75%), Genprex, Inc. (6.94%), Addex Therapeutics Ltd (0.24%), Turnstone Biologics Corp. (2.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Evaxion Biotech A/S stock? Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evaxion Biotech A/S? A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further. How often is Evaxion Biotech A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies PharmaCyte Biotech Short Interest Data Mainz Biomed Short Interest Data Creative Medical Technology Short Interest Data Carisma Therapeutics Short Interest Data HCW Biologics Short Interest Data Talphera Short Interest Data Ainos Short Interest Data Genprex Short Interest Data Addex Therapeutics Short Interest Data Turnstone Biologics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVAX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVAX Stock Free EVAX Stock Alerts